Normalization of pre-ASCT, FDG-PET imaging with second-line, non–cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma

We previously reported that remission duration < 1 year, extranodal disease, and B symptoms before salvage chemotherapy (SLT) can stratify relapsed or refractory Hodgkin lymphoma (HL) patients into favorable and unfavorable cohorts. In addition, pre-autologous stem cell transplant (ASCT) (18)FDG-...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Moskowitz, Craig H., Matasar, Matt J., Zelenetz, Andrew D., Nimer, Stephen D., Gerecitano, John, Hamlin, Paul, Horwitz, Steven, Moskowitz, Alison J., Noy, Ariela, Palomba, Lia, Perales, Miguel-Angel, Portlock, Carol, Straus, David, Maragulia, Jocelyn C., Schoder, Heiko, Yahalom, Joachim
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2012
Matèries:
Clinical Trials and Observations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3790950/
https://ncbi.nlm.nih.gov/pubmed/22184409
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-10-388058
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars